Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: A 7-year follow-up study

Caterina Clemente, Silvana Elba, Gianpiero Buongiorno, Vito Guerra, Benedetta D'Attoma, Antonella Orlando, Francesco Russo

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aims: To evaluate possible modifications in the manganese superoxide dismutase (MnSOD) activity during neoplastic transformation of a cirrhotic liver and to find out whether its assessment may have predictive value to identify cirrhotic patients at a higher risk of hepatocellular carcinoma (HCC). Methods: Seventy-one consecutive subjects with Child-Pugh class A liver cirrhosis were recruited. At the time of enrolment, HCC was diagnosed in 20 cirrhotic patients. The 51 cirrhotic patients without HCC were followed up for the occurrence of tumour by 6-monthly screening for 7 years. During follow-up, 16 patients developed HCC. Seventy healthy subjects formed the control group. MnSOD activity was assayed spectrophotometrically. Results: Serum MnSOD activity was significantly lower in 70 healthy subjects compared with 51 cirrhotic patients and 20 cirrhotic patients with HCC. Cirrhotic patients who developed HCC during follow-up showed significantly higher values of MnSOD activity than HCC-free patients. The best cut-off of MnSOD activity was 0.40U/ml. At this cut-off, x 2 analysis revealed that MnSOD activity was significantly different between the HCC-free cirrhotic patients and cirrhotic patients who developed HCC. Conclusion: The present findings suggest that during neoplastic transformation of cirrhotic liver, an increase in MnSOD activity may occur already during the precancerous phase, making this enzyme a probable malignancy-associated parameter.

Original languageEnglish
Pages (from-to)791-797
Number of pages7
JournalLiver International
Volume27
Issue number6
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Liver Cirrhosis
Superoxide Dismutase
Hepatocellular Carcinoma
Incidence
Healthy Volunteers
Liver
Neoplasms
Control Groups
Enzymes
Serum

Keywords

  • Hepatocellular carcinoma
  • Liver cirrhosis
  • Manganese superoxide dismutase

ASJC Scopus subject areas

  • Hepatology

Cite this

@article{ea300749df2240e8962fa2c21db94f45,
title = "Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: A 7-year follow-up study",
abstract = "Aims: To evaluate possible modifications in the manganese superoxide dismutase (MnSOD) activity during neoplastic transformation of a cirrhotic liver and to find out whether its assessment may have predictive value to identify cirrhotic patients at a higher risk of hepatocellular carcinoma (HCC). Methods: Seventy-one consecutive subjects with Child-Pugh class A liver cirrhosis were recruited. At the time of enrolment, HCC was diagnosed in 20 cirrhotic patients. The 51 cirrhotic patients without HCC were followed up for the occurrence of tumour by 6-monthly screening for 7 years. During follow-up, 16 patients developed HCC. Seventy healthy subjects formed the control group. MnSOD activity was assayed spectrophotometrically. Results: Serum MnSOD activity was significantly lower in 70 healthy subjects compared with 51 cirrhotic patients and 20 cirrhotic patients with HCC. Cirrhotic patients who developed HCC during follow-up showed significantly higher values of MnSOD activity than HCC-free patients. The best cut-off of MnSOD activity was 0.40U/ml. At this cut-off, x 2 analysis revealed that MnSOD activity was significantly different between the HCC-free cirrhotic patients and cirrhotic patients who developed HCC. Conclusion: The present findings suggest that during neoplastic transformation of cirrhotic liver, an increase in MnSOD activity may occur already during the precancerous phase, making this enzyme a probable malignancy-associated parameter.",
keywords = "Hepatocellular carcinoma, Liver cirrhosis, Manganese superoxide dismutase",
author = "Caterina Clemente and Silvana Elba and Gianpiero Buongiorno and Vito Guerra and Benedetta D'Attoma and Antonella Orlando and Francesco Russo",
year = "2007",
month = "8",
doi = "10.1111/j.1478-3231.2007.01485.x",
language = "English",
volume = "27",
pages = "791--797",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis

T2 - A 7-year follow-up study

AU - Clemente, Caterina

AU - Elba, Silvana

AU - Buongiorno, Gianpiero

AU - Guerra, Vito

AU - D'Attoma, Benedetta

AU - Orlando, Antonella

AU - Russo, Francesco

PY - 2007/8

Y1 - 2007/8

N2 - Aims: To evaluate possible modifications in the manganese superoxide dismutase (MnSOD) activity during neoplastic transformation of a cirrhotic liver and to find out whether its assessment may have predictive value to identify cirrhotic patients at a higher risk of hepatocellular carcinoma (HCC). Methods: Seventy-one consecutive subjects with Child-Pugh class A liver cirrhosis were recruited. At the time of enrolment, HCC was diagnosed in 20 cirrhotic patients. The 51 cirrhotic patients without HCC were followed up for the occurrence of tumour by 6-monthly screening for 7 years. During follow-up, 16 patients developed HCC. Seventy healthy subjects formed the control group. MnSOD activity was assayed spectrophotometrically. Results: Serum MnSOD activity was significantly lower in 70 healthy subjects compared with 51 cirrhotic patients and 20 cirrhotic patients with HCC. Cirrhotic patients who developed HCC during follow-up showed significantly higher values of MnSOD activity than HCC-free patients. The best cut-off of MnSOD activity was 0.40U/ml. At this cut-off, x 2 analysis revealed that MnSOD activity was significantly different between the HCC-free cirrhotic patients and cirrhotic patients who developed HCC. Conclusion: The present findings suggest that during neoplastic transformation of cirrhotic liver, an increase in MnSOD activity may occur already during the precancerous phase, making this enzyme a probable malignancy-associated parameter.

AB - Aims: To evaluate possible modifications in the manganese superoxide dismutase (MnSOD) activity during neoplastic transformation of a cirrhotic liver and to find out whether its assessment may have predictive value to identify cirrhotic patients at a higher risk of hepatocellular carcinoma (HCC). Methods: Seventy-one consecutive subjects with Child-Pugh class A liver cirrhosis were recruited. At the time of enrolment, HCC was diagnosed in 20 cirrhotic patients. The 51 cirrhotic patients without HCC were followed up for the occurrence of tumour by 6-monthly screening for 7 years. During follow-up, 16 patients developed HCC. Seventy healthy subjects formed the control group. MnSOD activity was assayed spectrophotometrically. Results: Serum MnSOD activity was significantly lower in 70 healthy subjects compared with 51 cirrhotic patients and 20 cirrhotic patients with HCC. Cirrhotic patients who developed HCC during follow-up showed significantly higher values of MnSOD activity than HCC-free patients. The best cut-off of MnSOD activity was 0.40U/ml. At this cut-off, x 2 analysis revealed that MnSOD activity was significantly different between the HCC-free cirrhotic patients and cirrhotic patients who developed HCC. Conclusion: The present findings suggest that during neoplastic transformation of cirrhotic liver, an increase in MnSOD activity may occur already during the precancerous phase, making this enzyme a probable malignancy-associated parameter.

KW - Hepatocellular carcinoma

KW - Liver cirrhosis

KW - Manganese superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=34447337496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447337496&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2007.01485.x

DO - 10.1111/j.1478-3231.2007.01485.x

M3 - Article

C2 - 17617122

AN - SCOPUS:34447337496

VL - 27

SP - 791

EP - 797

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 6

ER -